Other pro-tumor EV effects include the role of the pro-coagulant transmembrane tissue factor molecule that modulates angiogenesis as well as metastasis in cancer [reviewed in (179)] and tissue factor-bearing MVs derived from colorectal carcinoma cells can contribute to a K-ras dependent cancer progression (180). This evidence concerns the gene KRAS and cancer.